Los puntos clave no están disponibles para este artículo en este momento.
Due to increasing antimicrobial resistance and warnings against moxifloxacin use, indications for testing and treatment have been narrowed to primarily involve symptomatic patients. The importance of macrolide resistance-guided therapy is emphasised.
Jensen et al. (Sat,) studied this question.